acquisitionGSK closes US$50m acquisition with Elsie Biotechnologies IncLatest News GSK takes over Elsie Biotechnologies in US$50m deal to boost its oligonucleotide-based drug platform and pipeline. Read more 7 June 2024 https://european-biotechnology.com/wp-content/uploads/2024/06/Elsie.png 716 1220 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-06-07 11:19:412024-07-07 09:26:18GSK closes US$50m acquisition with Elsie Biotechnologies Inc